Showing results (1-10 of 405) with videos related to

Sort By:
Pageof 41
Virologie (Montrouge, France)|May 28, 2019
[Recent advances in understanding and diagnosing hepatitis B virus infection]Slim Fourati, Jean-Michel Pawlotsky
F1000Research|September 17, 2016
Recent advances in understanding and diagnosing hepatitis B virus infectionSlim Fourati, Jean-Michel Pawlotsky
Viruses|December 23, 2015
Virologic Tools for HCV Drug Resistance TestingSlim Fourati, Jean-Michel Pawlotsky
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 27, 2017
Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assaySlim Fourati, Dominique Challine, Jean-Dominique Poveda, et al.
Hepatology (Baltimore, Md.)|August 21, 2018
Frequent Antiviral Treatment Failures in Patients Infected With Hepatitis C Virus Genotype 4, Subtype 4rSlim Fourati, Christophe Rodriguez, Christophe Hézode, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Virological characterization of treatment failures and retreatment outcomes in patients infected with "unusual" HCV genotype 1 subtypesErwan Vo-Quang, Alexandre Soulier, Mélissa Ndebi, et al.
Emerging Infectious Diseases|May 6, 2022
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022Slim Fourati, Guillaume Gautier, Myriam Chovelon, et al.
JAMA Oncology|January 7, 2022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer AgentsCharlotte Fenioux, Luis Teixeira, Slim Fourati, et al.
Antiviral Therapy|May 22, 2019
Performance assessment of a fully automated deep sequencing platform for HCV resistance testingChristophe Rodriguez, Mélanie Mercier-Darty, Alexandre Soulier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2021
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease SeverityBenoit Bailly, Luc Guilpain, Kevin Bouiller, et al.
Pageof 41